Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.69
-0.14 (-1.79%)
Nov 20, 2024, 4:00 PM EST - Market closed
Profound Medical Employees
Profound Medical had 131 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
131
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$68,580
Profits / Employee
-$239,626
Market Cap
188.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
InfuSystem Holdings | 516 |
Jin Medical International | 245 |
Cellectis | 221 |
Sight Sciences | 214 |
Nektar Therapeutics | 137 |
Acrivon Therapeutics | 61 |
Lexeo Therapeutics | 58 |
PROF News
- 11 days ago - Profound Medical Corporation (PROF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 - GlobeNewsWire
- 4 weeks ago - Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow - GlobeNewsWire
- 5 weeks ago - Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Profound Medical to Participate in Lake Street's Best Ideas Growth Conference - GlobeNewsWire
- 3 months ago - Profound Medical Corporation (PROF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow - GlobeNewsWire
- 4 months ago - Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases - GlobeNewsWire